Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
It was reported that the patient had a lead revision due to high impedance.Impedance values with the new lead was within normal limits.The surgeon, scrub tech, and company representative looked over the explanted lead and could find no gross abnormalities or visible breaks.The explanted lead was discarded and is not available for return to the manufacturer.The patient's physician later reported that x-rays were taken.They have not been provided to livanova for review.The following troubleshooting was attempted in the operating room when high impedance was first seen on 1/9/2024 and again prior to the lead revision on 2/9/2024: pin re-insertion, visualizing the pin past the setscrew connector block, irrigating the header with saline, and visualizing the lead for any breaks.A test resistor was not used during troubleshooting.No other relevant information has been received to date.
|